EFAVIRENZ
Generic: EFAVIRENZ
Aurobindo Pharma LimitedManufacturer
ORALRoute
EFAVIRENZActive Substance
2018-09-21Original Approval
EFAVIRENZ is FDA application ANDA077673, sponsored by AUROBINDO PHARMA LTD. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
VIROLOGIC FAILURE
960 reports
2
DRUG INTERACTION
762 reports
3
DRUG RESISTANCE
742 reports
4
VIRAL MUTATION IDENTIFIED
676 reports
5
PATHOGEN RESISTANCE
642 reports
6
FOETAL EXPOSURE DURING PREGNANCY
621 reports
7
DEPRESSION
465 reports
8
MATERNAL EXPOSURE DURING PREGNANCY
433 reports
9
TREATMENT FAILURE
423 reports
10
ANAEMIA
419 reports